NCT04958564 is a NA clinical trial of DCP in Transverse Fracture of Shaft of Tibia, sponsored by District Headquarters Teaching Hospital Sahiwal.

Who is sponsoring NCT04958564?

NCT04958564 is sponsored by District Headquarters Teaching Hospital Sahiwal.

What drugs are being tested in NCT04958564?

Interventions in NCT04958564: DCP.

What condition does NCT04958564 study?

NCT04958564 studies Transverse Fracture of Shaft of Tibia.

Is NCT04958564 still recruiting?

NCT04958564 is currently completed. Last updated 12 July 2021.

Last reviewed 2021-07-12 · How we verify

NCT04958564

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Interlock Nailing Versus Dynamic Compression Plating in Transverse Fractures of Tibia

Completed NA Last updated 12 July 2021

What this trial tests

NA trial testing DCP in Transverse Fracture of Shaft of Tibia in 70 participants. Completed in 20 January 2020.

Timeline

20 January 2019

Primary endpoint
20 January 2020

20 January 2020

Quick facts

Lead sponsor	District Headquarters Teaching Hospital Sahiwal
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	health services research
Enrollment	70
Start date	20 January 2019
Primary completion	20 January 2020
Estimated completion	20 January 2020
Sites	1 location across Pakistan

Drugs / interventions tested

Conditions studied

Transverse Fracture of Shaft of Tibia — all drugs for Transverse Fracture of Shaft of Tibia →

Sponsor

District Headquarters Teaching Hospital Sahiwal

Who can join

Eligibility, any sex, with Transverse Fracture of Shaft of Tibia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Study aims to compare two treatment modalities for treatment of transverse fractures of tibia. One is Intramedullary interlocking nail and the other is dynamic compression plate.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other District Headquarters Teaching Hospital Sahiwal trials

Trials by the same sponsor.

NCT06975488 — Effectiveness of LASER in Treatment of Ureteric Stones. · NA · completed
NCT07394725 — Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management · Phase 1 · completed
NCT06707051 — Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin · Phase 2, PHASE3 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04958564 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by District Headquarters Teaching Hospital Sahiwal
Last refreshed: 12 July 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04958564.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing